Active substances
Codeine + Paracetamol
- SFDA 1
- US FDA 112
- Health Canada 4
- US price lines 4
- NHS prices 16
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| REVACOD | 500, 10 mg | Tablet · Oral use | 20 Blister | SAR 4.10 | NCE · Prescription | APM | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;60MG | tablet · oral | SUN PHARM INDS LTD | Prescription | 23 Jan 1980 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 120MG/5ML;12MG/5ML | solution · oral | GENUS LIFESCIENCES | Prescription | 21 Aug 1981 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;30MG | tablet · oral | STRIDES PHARMA INTL | Prescription | 30 Sep 1988 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;60MG | tablet · oral | STRIDES PHARMA INTL | Prescription | 30 Sep 1988 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;15MG | tablet · oral | STRIDES PHARMA INTL | Prescription | 30 Sep 1988 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;15MG; 300MG;30MG; 300MG;60MG | tablet · oral | SPECGX LLC | Prescription | 31 May 2001 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;30MG | tablet · oral | AMNEAL PHARMS NY | Prescription | 29 May 2008 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;15MG; 300MG;30MG; 300MG;60MG | tablet · oral | AUROLIFE PHARMA LLC | Prescription | 15 Apr 2013 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;15MG; 300MG;30MG; 300MG;60MG | tablet · oral | ADAPTIS | Prescription | 27 Jun 2019 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;15MG; 300MG;30MG; 300MG;60MG | tablet · oral | ELITE LABS INC | Prescription | 10 Sep 2019 |
| CAPITAL AND CODEINE | 325MG;30MG | tablet · oral | CARNRICK | Discontinued | 31 May 1974 |
| PHENAPHEN W/ CODEINE NO. 3 | 325MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule · oral | ROBINS AH | Discontinued | 22 Jul 1975 |
| PHENAPHEN W/ CODEINE NO. 4 | 325MG;60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule · oral | ROBINS AH | Discontinued | 22 Jul 1975 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;30MG | tablet · oral | ROXANE | Discontinued | 10 May 1976 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;15MG | tablet · oral | ROXANE | Discontinued | 10 May 1976 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;60MG | tablet · oral | ROXANE | Discontinued | 10 May 1976 |
| TYLENOL W/ CODEINE | 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 325MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 325MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 325MG;60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | ORTHO MCNEIL PHARM | Discontinued | 9 Jul 1976 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;30MG | tablet · oral | SANDOZ | Discontinued | 10 Feb 1977 |
| TYLENOL W/ CODEINE NO. 1 | 300MG;7.5MG | tablet · oral | JANSSEN PHARMS | Discontinued | 17 Aug 1977 |
| TYLENOL W/ CODEINE NO. 2 | 300MG;15MG | tablet · oral | JANSSEN PHARMS | Discontinued | 17 Aug 1977 |
| TYLENOL W/ CODEINE NO. 3 | 300MG;30MG | tablet · oral | JANSSEN PHARMS | Discontinued | 17 Aug 1977 |
| TYLENOL W/ CODEINE NO. 4 | 300MG;60MG | tablet · oral | JANSSEN PHARMS | Discontinued | 17 Aug 1977 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 300MG;30MG | tablet · oral | KV PHARM | Discontinued | 23 Aug 1977 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 325MG;45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | KV PHARM | Discontinued | 23 Aug 1977 |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | 325MG;15MG | tablet · oral | KV PHARM | Discontinued | 23 Aug 1977 |
87 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| PMS-ACETAMINOPHEN WITH CODEINE ELIXIR | 00816027 | 8 MG / 5 ML; 160 MG / 5 ML | ELIXIR · ORAL | PHARMASCIENCE INC |
| TEVA-EMTEC-30 | 00608882 | 30 MG; 300 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-LENOLTEC NO. 4 | 00621463 | 60 MG; 300 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TRIATEC-30 | 00789828 | 300 MG; 30 MG | TABLET · ORAL | LABORATOIRE RIVA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ACETAMINOPHEN-COD #2 TABLET | $0.26941 | per EA | 23 Sep 2026 |
| US NADAC | ACETAMINOPHEN-COD #3 TABLET | $0.25557 | per EA | 23 Sep 2026 |
| US NADAC | ACETAMINOPHEN-COD #4 TABLET | $0.38902 | per EA | 23 Sep 2026 |
| US NADAC | ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION | $0.46877 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Co-codamol 12.8mg/500mg tablets | £5.04 | 24 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 15mg/500mg capsules | £7.25 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 15mg/500mg effervescent tablets sugar free | £12.88 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 15mg/500mg tablets | £3.63 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 30mg/500mg capsules | £6.20 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 30mg/500mg effervescent tablets | £2.53 | 32 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 30mg/500mg effervescent tablets | £7.91 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 30mg/500mg tablets | £2.57 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 30mg/500mg tablets | £8.57 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 8mg/500mg capsules | £5.72 | 32 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 8mg/500mg capsules | £17.87 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Co-codamol 8mg/500mg effervescent tablets | £3.24 | 32 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.